Novartis Ag (NVS) Other Non-Current Assets (2011 - 2026)

Novartis Ag has disclosed Other Non-Current Assets across 16 years of filings, most recently posting $5.9 billion for Q2 2026.

• In Q2 2026, Other Non-Current Assets rose 32.45% year-over-year to $5.9 billion; the TTM figure through Jun 2026 stood at $5.9 billion (up 32.45% YoY), while the FY2025 annual figure was $5.3 billion, up 50.5% from the prior year.
• Other Non-Current Assets came in at $5.9 billion for Q2 2026 at Novartis Ag, up from $5.0 billion in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $5.9 billion in Q2 2026 to a low of $1.1 billion in Q3 2023.
• Average Other Non-Current Assets over 5 years is $3.0 billion, with a median of $3.3 billion recorded in 2022.
• Year-over-year, Other Non-Current Assets plunged 68.91% in 2023 and soared 244.35% in 2025.
• Over 5 years, Other Non-Current Assets stood at $1.1 billion in 2022, then rose by 8.02% to $1.2 billion in 2023, then surged by 192.33% to $3.5 billion in 2024, then jumped by 50.5% to $5.3 billion in 2025, then advanced by 12.34% to $5.9 billion in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $5.9 billion in Q2 2026, $5.0 billion in Q1 2026, and $5.3 billion in Q4 2025.